Seminars in Pediatric Neurology
Volume 16, Issue 2 , Pages 82-89 , June 2009

Management of Spasticity in Children With Cerebral Palsy

  • Ann Tilton, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Ann Tilton, MD, Louisiana State University Health and Sciences Center, New Orleans, LA 70,118

References 

  1. Lance JW. Symposium synopsis. In:  Feldman RG,  Young RR,  Koella WP editor. Spasticity: Disordered Motor Control. Chicago: Yearbook Medical; 1980;p. 485–494
  2. Mayer NH, Esquenazi A, Childers MK. Common patterns of clinical motor dysfunction. In:  Brashear A,  Mayer NH editor. Spasticity and Other Forms of Muscle Overactivity in the Upper Motor Neuron Syndrome: Etiology, Evaluation, Management, and the Role of Botulinum Toxin. New York: WE MOVE; 2008;p. 27–38
  3. Russman BS, Gormley ME, Tilton A, et al. A rational approach to a treatment protocol, and the role of botulinum toxin in treatment. In:  Brashear A,  Mayer NH editor. Spasticity and Other Forms of Muscle Overactivity in the Upper Motor Neuron Syndrome: Etiology, Evaluation, Management, and the Role of Botulinum toxin. New York: WE MOVE; 2008;p. 179–192
  4. Verschuren O, Ketelaar M, Gorter JW, et al. Exercise training program in children and adolescents with cerebral palsy: A randomized controlled trial. Arch Pediatr Adolesc Med. 2007;161:1075–1081
  5. Sterba JA. Does horseback riding therapy or therapist-directed hippotherapy rehabilitate children with cerebral palsy?. Dev Med Child Neurol. 2007;49:68–73
  6. van Dijk H, Jannink MJ, Hermens HJ. Effect of augmented feedback on motor function of the affected upper extremity in rehabilitation patients: A systematic review of randomized controlled trials. J Rehabil Med. 2005;37:202–211
  7. Ozer K, Chesher SP, Scheker LR. Neuromuscular electrical stimulation and dynamic bracing for the management of upper-extremity spasticity in children with cerebral palsy. Dev Med Child Neurol. 2006;48:559–563
  8. van der Linden ML, Hazlewood ME, Aitchison AM, et al. Electrical stimulation of gluteus maximus in children with cerebral palsy: Effects on gait characteristics and muscle strength. Dev Med Child Neurol. 2003;45:385–390
  9. van der Linden ML, Hazlewood ME, Hillman SJ, et al. Functional electrical stimulation to the dorsiflexors and quadriceps in children with cerebral palsy. Pediatr Phys Ther. 2008;20:23–29
  10. Khalili MA, Hajihassanie A. Electrical simulation in addition to passive stretch has a small effect on spasticity and contracture in children with cerebral palsy: A randomised within-participant controlled trial. Aust J Physiother. 2008;54:185–189
  11. Dodd KJ, Taylor NF, Graham HK. A randomized clinical trial of strength training in young people with cerebral palsy. Dev Med Child Neurol. 2003;45:652–657
  12. Patikas D, Wolf SI, Mund K, et al. Effects of a postoperative strength-training program on the walking ability of children with cerebral palsy: A randomized controlled trial. Arch Phys Med Rehabil. 2006;87:619–626
  13. Unger M, Faure M, Frieg A. Strength training in adolescent learners with cerebral palsy: A randomized controlled trial. Clin Rehabil. 2006;20:469–477
  14. Scholtes VA, Dallmeijer AJ, Rameckers EA, et al. Lower limb strength training in children with cerebral palsy—A randomized controlled trial protocol for functional strength training based on progressive resistance exercise principles. BMC Pediatr. 2008;8:41
  15. Bower E, Michell D, Burnett M, et al. Randomized controlled trial of physiotherapy in 56 children with cerebral palsy followed for 18 months. Dev Med Child Neurol. 2001;43:4–15
  16. Weindling AM, Cunningham CC, Glenn SM, et al. Additional therapy for young children with spastic cerebral palsy: A randomised controlled trial. Health Technol Assess. 2007;1–7111:iii-x
  17. Christiansen AS, Lange C. Intermittent versus continuous physiotherapy in children with cerebral palsy. Dev Med Child Neurol. 2008;50:290–293
  18. Taub E, Ramey SL, DeLuca S, et al. Efficacy of constraint-induced movement therapy for children with cerebral palsy with asymmetric motor impairment. Pediatrics. 2004;113:305–312
  19. Charles JR, Wolf SL, Schneider JA, et al. Efficacy of a child-friendly form of constraint-induced movement therapy in hemiplegic cerebral palsy: A randomized control trial. Dev Med Child Neurol. 2006;48:635–642
  20. Deluca SC, Echols K, Law CR, et al. Intensive pediatric constraint-induced therapy for children with cerebral palsy: Randomized, controlled, crossover trial. J Child Neurol. 2006;21:931–938
  21. Gordon AM, Chinnan A, Gill S, et al. Both constraint-induced movement therapy and bimanual training lead to improved performance of upper extremity function in children with hemiplegia. Dev Med Child Neurol. 2008;50:957–958
  22. Sung IY, Ryu JS, Pyun SB, et al. Efficacy of forced-use therapy in hemiplegic cerebral palsy. Arch Phys Med Rehabil. 2005;86:2195–2198
  23. Charles JR, Gordon AM. A repeated course of constraint-induced movement therapy results in further improvement. Dev Med Child Neurol. 2007;49:770–773
  24. Carlson WE, Vaughan CL, Damiano DL, et al. Orthotic management of gait in spastic diplegia. Am J Phys Med Rehabil. 1997;76:219–225
  25. Wilson H, Haideri N, Song K, et al. Ankle-foot orthoses for preambulatory children with spastic diplegia. J Pediatr Orthop. 1997;17:370–376
  26. Bjornson KF, Schmale GA, Adamczyk-Foster A, et al. The effect of dynamic ankle foot orthoses on function in children with cerebral palsy. J Pediatr Orthop. 2006;26:773–776
  27. Milla PJ, Jackson AD. A controlled trial of baclofen in children with cerebral palsy. J Int Med Res. 1977;5:398–404
  28. Scheinberg A, Hall K, Lam LT, et al. Oral baclofen in children with cerebral palsy: A double-blind cross-over pilot study. J Paediatr Child Health. 2006;42:715–720
  29. Gracies JM, Nance P, Elovic E, et al. Traditional pharmacological treatments for spasticity (Part II: General and regional treatments). Muscle Nerve Suppl. 1997;6:S92–S120
  30. Brin IL, Kurenkov AL, Gotlib VI. [the use of sirdalud in cerebral palsy in children]. Zh Nevrol Psikhiatr Im S S Korsakova. 1999;99:30–33
  31. Engle HA. The effect of diazepam (Valium) in children with cerebral palsy: A double-blind study. Dev Med Child Neurol. 1966;8:661–667
  32. Holt KS. The use of diazepam in childhood cerebral palsy (Report of a small study including electromyographic observations). Ann Phys Med Suppl. 1964;16–24
  33. Hiller CJ, Mason JL. Therapeutic test of diazepam (valium) in cerebral palsy. J S C Med Assoc. 1966;62:306–309
  34. Carter CH. Evaluation of diazepam in skeletal muscle hypertonicity in cerebral palsy. Arch Phys Med Rehabil. 1968;49:519–523
  35. Marsh Ho. Diazepam in incapacitated cerebral-palsied children. JAMA. 1965;191:797–800
  36. Mathew A, Mathew MC, Thomas M, et al. The efficacy of diazepam in enhancing motor function in children with spastic cerebral palsy. J Trop Pediatr. 2005;51:109–113
  37. Nogen AG. Medical treatment for spasticity in children with cerebral palsy. Childs Brain. 1976;2:304–308
  38. Mathew A, Mathew MC. Bedtime diazepam enhances well-being in children with spastic cerebral palsy. Pediatr Rehabil. 2005;8:63–66
  39. Haslam RH, Walcher JR, Lietman PS, et al. Dantrolene sodium in children with spasticity. Arch Phys Med Rehab. 1974;55:384–388
  40. Tardieu G, Tardieu C, Hariga J, et al. Treatment of spasticity in injection of dilute alcohol at the motor point or by epidural route (Clinical extension of an experiment on the decerebrate cat). Dev Med Child Neurol. 1968;10:555–568
  41. Spira R. Management of spasticity in cerebral palsied children by peripheral nerve block with phenol. Dev Med Child Neurol. 1971;13:164–173
  42. Yadav SL, Singh U, Dureja GP, et al. Phenol block in the management of spastic cerebral palsy. Indian J Pediatr. 1994;61:249–255
  43. Tilton AH. Injectable neuromuscular blockade in the treatment of spasticity and movement disorders. J Child Neurol. 2003;18(Suppl 1):S50–S66
  44. Sanger TD, Kukke SN, Sherman-Levine S. Botulinum toxin type B improves the speed of reaching in children with cerebral palsy and arm dystonia: An open-label, dose-escalation pilot study. J Child Neurol. 2007;22:116–122
  45. Gooch JL, Patton CP. Combining botulinum toxin and phenol to manage spasticity in children. Arch Phys Med Rehabil. 2004;85:1121–1124
  46. Dressler D, Eleopra R. Clinical use of non-A botulinum toxins: Botulinum toxin type B. Neurotox Res. 2006;9:121–125
  47. Corry IS, Cosgrove AP, Walsh EG, et al. Botulinum toxin A in the hemiplegic upper limb: A double-blind trial. Dev Med Child Neurol. 1997;39:185–193
  48. Koman LA, Mooney JF, Smith BP, et al. Management of spasticity in cerebral palsy with botulinum-A toxin: Report of a preliminary, randomized, double-blind trial. J Pediatr Orthop. 1994;14:299–303
  49. Fehlings D, Rang M, Glazier J, et al. An evaluation of botulinum-A toxin injections to improve upper extremity function in children with hemiplegic cerebral palsy. J Pediatr. 2000;137:331–337
  50. Fehlings D, Rang M, Glazier J, et al. Botulinum toxin type a injections in the spastic upper extremity of children with hemiplegia: Child characteristics that predict a positive outcome. Eur J Neurol. 2001;8(Suppl 5):145–149
  51. Love SC, Valentine JP, Blair EM, et al. The effect of botulinum toxin type A on the functional ability of the child with spastic hemiplegia a randomized controlled trial. Eur J Neurol. 2001;8(Suppl 5):50–58
  52. Ubhi T, Bhakta BB, Ives HL, et al. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy. Arch Dis Child. 2000;83:481–487
  53. Steenbeek D, Meester-Delver A, Becher JG, et al. The effect of botulinum toxin type A treatment of the lower extremity on the level of functional abilities in children with cerebral palsy: Evaluation with goal attainment scaling. Clin Rehabil. 2005;19:274–282
  54. Redman TA, Finn JC, Bremner AP, et al. Effect of upper limb botulinum toxin-A therapy on health-related quality of life in children with hemiplegic cerebral palsy. J Paediatr Child Health. 2008;44:409–414
  55. Barwood S, Baillieu C, Boyd R, et al. Analgesic effects of botulinum toxin A: A randomized, placebo-controlled clinical trial. Dev Med Child Neurol. 2000;42:116–121
  56. Flett PJ, Stern LM, Waddy H, et al. Botulinum toxin A versus fixed cast stretching for dynamic calf tightness in cerebral palsy. J Paediatr Child Health. 1999;35:71–77
  57. Ackman JD, Russman BS, Thomas SS, et al. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol. 2005;47:620–627
  58. Kay RM, Rethlefsen SA, Fern-Buneo A, et al. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am. 2004;86-A:2377–2384
  59. Glanzman AM, Kim H, Swaminathan K, et al. Efficacy of botulinum toxin A, serial casting, and combined treatment for spastic equinus: A retrospective analysis. Dev Med Child Neurol. 2004;46:807–811
  60. Desloovere K, Molenaers G, Jonkers I, et al. A randomized study of combined botulinum toxin type A and casting in the ambulant child with cerebral palsy using objective outcome measures. Eur J Neurol. 2001;8(Suppl 5):75–87
  61. Bottos M, Benedetti MG, Salucci P, et al. Botulinum toxin with and without casting in ambulant children with spastic diplegia: A clinical and functional assessment. Dev Med Child Neurol. 2003;45:758–762
  62. Booth MY, Yates CC, Edgar TS, et al. Serial casting vs combined intervention with botulinum toxin A and serial casting in the treatment of spastic equinus in children. Pediatr Phys Ther. 2003;15:216–220
  63. Newman CJ, Kennedy A, Walsh M, et al. A pilot study of delayed versus immediate serial casting after botulinum toxin injection for partially reducible spastic equinus. J Pediatr Orthop. 2007;27:882–885
  64. Bjornson K, Hays R, Graubert C, et al. Botulinum toxin for spasticity in children with cerebral palsy: A comprehensive evaluation. Pediatrics. 2007;120:49–58
  65. Moore AP, de-Hall RA, Smith CT, et al. Two-year placebo-controlled trial of botulinum toxin A for leg spasticity in cerebral palsy. Neurology. 2008;71:122–128
  66. Brashear A, Mayer NH. Dosing and administration of botulinum toxin for muscle overactivity in adults with an upper motor neuron syndrome. In:  Brashear A,  Mayer NH editor. Spasticity and Other Forms of Muscle Overactivity in the Upper Motor Neuron Syndrome: Etiology, Evaluation, Management, and the Role of Botulinum toxin. New York: WE MOVE; 2008;p. 207–218
  67. Boyd RN. GJNGeal Medium-term response characterisation and risk factor analysis of botulinum toxin type A in the management of spasticity in children with cerebral palsy. Eur J Neurol. 1999;6:S37–S45
  68. Delgado MR. The use of botulinum toxin type A in children with cerebral palsy: A retrospective study. Eur J Neurol. 1999;6(suppl 4):S11–S18
  69. Jankovic J, Vuong KD, Ahsan J. Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia. Neurology. 2003;60:1186–1188
  70. Dressler D, Bigalke H, Benecke R. Botulinum toxin type B in antibody-induced botulinum toxin type A therapy failure. J Neurol. 2003;250:967–969
  71. Smyth MD, Peacock WJ. The surgical treatment of spasticity. Muscle Nerve. 2000;23:153–163
  72. Hays RM, McLaughlin JF, Bjornson KF, et al. Electrophysiological monitoring during selective dorsal rhizotomy, and spasticity and GMFM performance. Dev Med Child Neurol. 1998;40:233–238
  73. Engsberg JR, Ross SA, Park TS. Changes in ankle spasticity and strength following selective dorsal rhizotomy and physical therapy for spastic cerebral palsy. J Neurosurg. 1999;91:727–732
  74. Engsberg JR, Ross SA, Wagner JM, et al. Changes in hip spasticity and strength following selective dorsal rhizotomy and physical therapy for spastic cerebral palsy. Dev Med Child Neurol. 2002;44:220–226
  75. Buckon CE, Thomas SS, Piatt JH, et al. Selective dorsal rhizotomy versus orthopedic surgery: A multidimensional assessment of outcome efficacy. Arch Phys Med Rehabil. 2004;85:457–465
  76. McLaughlin JF, Bjornson KF, Astley SJ, et al. Selective dorsal rhizotomy: Efficacy and safety in an investigator-masked randomized clinical trial. Dev Med Child Neurol. 1998;40:220–232
  77. Wright FV, Sheil EM, Drake JM, et al. Evaluation of selective dorsal rhizotomy for the reduction of spasticity in cerebral palsy: a randomized controlled tria. Dev Med Child Neurol. 1998;40:239–247
  78. Buckon CE, Thomas SS, Harris GE, et al. Objective measurement of muscle strength in children with spastic diplegia after selective dorsal rhizotomy. Arch Phys Med Rehabil. 2002;83:454–460
  79. Steinbok P, Schrag C. Complications after selective posterior rhizotomy for spasticity in children with cerebral palsy. Pediatr Neurosurg. 1998;28:300–313
  80. Chicoine MR, Park TS, Kaufman BA. Selective dorsal rhizotomy and rates of orthopedic surgery in children with spastic cerebral palsy. J Neurosurg. 1997;86:34–39
  81. Albright AL, Cervi A, Singletary J. Intrathecal baclofen for spasticity in cerebral palsy. JAMA. 1991;265:1418–1422
  82. Gilmartin R, Bruce D, Storrs BB, et al. Intrathecal baclofen for management of spastic cerebral palsy: Multicenter trial. J Child Neurol. 2000;15:71–77
  83. Van SP, Nuttin B, Lagae L, et al. Intrathecal baclofen for intractable cerebral spasticity: A prospective placebo-controlled, double-blind study. Neurosurgery. 2000;46:603–609
  84. Awaad Y, Tayem H, Munoz S, et al. Functional assessment following intrathecal baclofen therapy in children with spastic cerebral palsy. J Child Neurol. 2003;18:26–34
  85. de Lissovoy G, Matza LS, Green H, et al. Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy. J Child Neurol. 2007;22:49–59
  86. Coffey RJ, Edgar TS, Francisco GE, et al. Abrupt withdrawal from intrathecal baclofen: Recognition and management of a potentially life-threatening syndrome. Arch Phys Med Rehabil. 2002;83:735–741
  87. Cornell MS. The hip in cerebral palsy. Dev Med Child Neurol. 1995;37:3–18

PII: S1071-9091(09)00013-8

doi: 10.1016/j.spen.2009.03.006

Seminars in Pediatric Neurology
Volume 16, Issue 2 , Pages 82-89 , June 2009

Article Tools